Amanta Healthcare commissioned its new SteriPort facility at Kheda. This advanced, automated line enhances product quality and patient safety. The company expects this brownfield expansion to boost operational and financial efficiency, leading to EBITDA margin expansion.
Amanta Healthcare will hold its 31st AGM via VC/OAVM, with the Annual Report for FY26 available online for shareholders.
Here's a summary of the company updates, following your preferences: **Amanta Healthcare Limited:** Announced board meeting for financial results. **Gee Cee Ventures Limited:** Board approved financial results. Company reduced stake in a subsidiary, it became an associate. **HCL Infosystems Limited:** Board approved financial results. **Krebs Biochemicals & Industries Limited:** Board...
Amanta Healthcare reports Q1FY27 results: Revenue up 5.4% to ₹68.8 Cr. EBITDA at ₹15.2 Cr, margins at 22%. PAT ₹3.3 Cr, impacted by finance costs. Steriport plant commissioning expected soon.
Amanta Healthcare confirms no deviation in IPO fund utilization. Funds were used for manufacturing lines and corporate purposes, with minor adjustments for GST expenses.
